8-(3-(4-(2-Ethoxyphenyl)piperazin-1-yl)-2-hydroxypropoxy)-7-methoxy-3-methylisochroman-4-one

ID: ALA4457221

Chembl Id: CHEMBL4457221

PubChem CID: 155526180

Max Phase: Preclinical

Molecular Formula: C26H34N2O6

Molecular Weight: 470.57

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCOc1ccccc1N1CCN(CC(O)COc2c(OC)ccc3c2COC(C)C3=O)CC1

Standard InChI:  InChI=1S/C26H34N2O6/c1-4-32-23-8-6-5-7-22(23)28-13-11-27(12-14-28)15-19(29)16-34-26-21-17-33-18(2)25(30)20(21)9-10-24(26)31-3/h5-10,18-19,29H,4,11-17H2,1-3H3

Standard InChI Key:  BGRPUCGUHUNFKR-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4457221

    ---

Associated Targets(non-human)

Thoracic aorta (838 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 470.57Molecular Weight (Monoisotopic): 470.2417AlogP: 2.76#Rotatable Bonds: 9
Polar Surface Area: 80.70Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.37CX LogP: 2.69CX LogD: 2.65
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.60Np Likeness Score: -0.52

References

1. Xie S, Li X, Yu H, Zhang P, Wang J, Wang C, Xu S, Wu Z, Liu J, Zhu Z, Xu J..  (2019)  Design, synthesis and biological evaluation of isochroman-4-one hybrids bearing piperazine moiety as antihypertensive agent candidates.,  27  (13): [PMID:31078380] [10.1016/j.bmc.2019.05.004]

Source